Supplementary Figure S1 from Evaluation of Copanlisib in Combination with Eribulin in Triple-negative Breast Cancer Patient-derived Xenograft Models | Synapse
June 5, 2024Open Access
Supplementary Figure S1 from Evaluation of Copanlisib in Combination with Eribulin in Triple-negative Breast Cancer Patient-derived Xenograft Models
Puntos clave
Los puntos clave no están disponibles para este artículo en este momento.
Resumen
Tumor growth response of TNBC PDX models to eribulin monotherapy